Evicenter
P&T meetings

Tirabrutinib

Primary central nervous system lymphoma

Regulatory submission
NDA submitted December 2025
Last updated
72 sources

Executive summary

Burden of Primary central nervous system lymphoma

1 evidence topic · 3 sources

Summary

In U.S. registry data, PCNSL incidence increased from 0.1 to 0.5 per 100,000 between 1975 and 2017. Presentations include headaches, seizures, limb weakness, confusion, and visual or hearing disturbances. A Taiwan study reported mean direct healthcare costs exceeding 1 million TWD, approximately 35,000 USD, concentrated in the first year after diagnosis.